title: The biotechnology era: has the promise been fulfilled?
abstract: Biotechnological advances have changed the traditional landscape of the drug discovery process. Mutually beneficial relationships between small, innovative and nimble biotechnology companies and experienced, well-funded pharmaceutical companies have resulted in a more rapid application of new technologies to drug development and diversification. Protein-based drugs, such as therapeutic monoclonal antibodies, exemplify the fulfillment of the promise of the biotechnology revolution.
authors.affiliation: Divisional Vice President Biologics, Abbott Bioresearch Center, 100 Research Drive, Worcester, MA 01605, USA +1 508 849 2566 ; +1 508 754 7481 ; jochen.salfeld@abbott.com.
authors.forename: Jochen G
authors.initials: JG
authors.lastname: Salfeld